These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 10734298)
1. Resveratrol selectively inhibits leukemia cells: a prospective agent for ex vivo bone marrow purging. Gautam SC; Xu YX; Dumaguin M; Janakiraman N; Chapman RA Bone Marrow Transplant; 2000 Mar; 25(6):639-45. PubMed ID: 10734298 [TBL] [Abstract][Full Text] [Related]
2. Efficacy and toxicity of 9-beta-D-arabinofuranosylguanine (araG) as an agent to purge malignant T cells from murine bone marrow: application to an in vivo T-leukemia model. Gravatt LC; Chaffee S; Hebert ME; Halperin EC; Friedman HS; Kurtzberg J Leukemia; 1993 Aug; 7(8):1261-7. PubMed ID: 8350627 [TBL] [Abstract][Full Text] [Related]
3. Guanine arabinoside as a bone marrow-purging agent. Kurtzberg J Ann N Y Acad Sci; 1993 Jun; 685():225-36. PubMed ID: 8363226 [TBL] [Abstract][Full Text] [Related]
5. Disparate in vitro and in vivo antileukemic effects of resveratrol, a natural polyphenolic compound found in grapes. Gao X; Xu YX; Divine G; Janakiraman N; Chapman RA; Gautam SC J Nutr; 2002 Jul; 132(7):2076-81. PubMed ID: 12097696 [TBL] [Abstract][Full Text] [Related]
6. Antileukemic effect of interleukin-2-transduced murine bone marrow after autologous transplantation. Tam YK; Klingemann HG Biol Blood Marrow Transplant; 1999; 5(4):231-42. PubMed ID: 10465103 [TBL] [Abstract][Full Text] [Related]
7. Use of etoposide in combination with cyclosporin for purging multidrug-resistant leukemic cells from bone marrow in a mouse model. Kühl JS; Sikic BI; Blume KG; Chao NJ Exp Hematol; 1992 Oct; 20(9):1048-54. PubMed ID: 1468539 [TBL] [Abstract][Full Text] [Related]
8. Leukemia inhibitory factor induces in vivo expansion of bone marrow progenitor cells that accelerate hematopoietic reconstitution but do not enhance radioprotection in lethally irradiated mice. Pruijt JF; Lindley IJ; Heemskerk DP; Willemze R; Fibbe WE Stem Cells; 1997; 15(1):50-5. PubMed ID: 9007222 [TBL] [Abstract][Full Text] [Related]
10. Purging of leukemia-contaminated bone marrow grafts using suicide adenoviral vectors: an in vivo murine experimental model. Garcia-Castro J; Rio P; Lillo R; Garcia-Sanchez F; Segovia JC; Bueren JA Gene Ther; 2003 Aug; 10(16):1328-35. PubMed ID: 12883529 [TBL] [Abstract][Full Text] [Related]
11. Role of cytoprotective mechanisms in the photochemical purging of autologous bone marrow grafts. Yamazaki T; Sato Y; Sieber F Exp Hematol; 1997 Jul; 25(7):629-37. PubMed ID: 9216739 [TBL] [Abstract][Full Text] [Related]
12. Goralatide (AcSDKP) selectively protects murine hematopoietic progenitors and stem cells against hyperthermic damage. Wierenga PK; Konings AW Exp Hematol; 1996 Feb; 24(2):246-52. PubMed ID: 8641348 [TBL] [Abstract][Full Text] [Related]
13. Ex vivo expansion of murine hematopoietic progenitor cells generates classes of expanded cells possessing different levels of bone marrow repopulating potential. Traycoff CM; Cornetta K; Yoder MC; Davidson A; Srour EF Exp Hematol; 1996 Feb; 24(2):299-306. PubMed ID: 8641356 [TBL] [Abstract][Full Text] [Related]
14. Induction of apoptosis by 3,4'-dimethoxy-5-hydroxystilbene in human promyeloid leukemic HL-60 cells. Lee SH; Ryu SY; Kim HB; Kim MY; Chun YJ Planta Med; 2002 Feb; 68(2):123-7. PubMed ID: 11859461 [TBL] [Abstract][Full Text] [Related]
15. Selective growth inhibition of human leukemia and human lymphoblastoid cells by resveratrol via cell cycle arrest and apoptosis induction. Lee SK; Zhang W; Sanderson BJ J Agric Food Chem; 2008 Aug; 56(16):7572-7. PubMed ID: 18656932 [TBL] [Abstract][Full Text] [Related]
16. The sensitivity of leukemic bone marrow to simvastatin is lost at remission: a potential purging agent for autologous bone marrow transplantation. Newman A; Clutterbuck RD; DeLord C; Powles RL; Catovsky D; Millar JL J Investig Med; 1995 Jun; 43(3):269-74. PubMed ID: 7614073 [TBL] [Abstract][Full Text] [Related]
17. Interleukin-12 (IL-12) gene therapy of leukemia: immune and anti-leukemic effects of IL-12-transduced hematopoietic progenitor cells. Gautam SC; Xu YX; Dumaguin M; Janakiraman N; Chapman RA Cancer Gene Ther; 2000 Jul; 7(7):1060-8. PubMed ID: 10917209 [TBL] [Abstract][Full Text] [Related]
18. Cytotoxic activity of an anti-transferrin receptor immunotoxin on normal and leukemic human hematopoietic progenitors. Cazzola M; Bergamaschi G; Dezza L; D'Uva R; Ponchio L; Rosti V; Ascari E Cancer Res; 1991 Jan; 51(2):536-41. PubMed ID: 1985771 [TBL] [Abstract][Full Text] [Related]
19. Interleukin-2 activation of human bone marrow in long-term cultures: an effective strategy for purging and generation of anti-tumor cytotoxic effectors. Verma UN; Bagg A; Brown E; Mazumder A Bone Marrow Transplant; 1994 Feb; 13(2):115-23. PubMed ID: 8205079 [TBL] [Abstract][Full Text] [Related]
20. The cytotoxicity of alkyl-lysophospholipid on clonogenic leukemia cells and on normal bone marrow progenitor cells is highly, but differentially, increased by cryopreservation. Verdonck LF; Heesbeen EC; van Heugten HG; Staal GE; Rijksen G Bone Marrow Transplant; 1992 Apr; 9(4):241-5. PubMed ID: 1600412 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]